MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.550
+0.080 (2.31%)
Dec 3, 2025, 4:00 PM EST - Market closed
MDxHealth Market Cap
MDxHealth has a market cap or net worth of $175.72 million as of December 4, 2025. Its market cap has increased by 126.58% in one year.
Market Cap
175.72M
Enterprise Value
231.61M
1-Year Change
126.58%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since the IPO on May 12, 2017, MDxHealth's market cap has decreased from $269.23M to $175.72M, a decrease of -34.73%. That is a compound annual growth rate of -4.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 175.72M | 56.79% |
| Dec 31, 2024 | 112.07M | 4.24% |
| Dec 29, 2023 | 107.52M | 659,987.71% |
| Dec 29, 2022 | 16.29K | -99.98% |
| Dec 30, 2020 | 91.60M | 18.07% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| May 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |